Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Qual Life Res. 2011 Oct 1;21(6):975–981. doi: 10.1007/s11136-011-0012-7

Fig. 3.

Fig. 3

Treatment retention. Percentage of patients retained in treatment across 8 weeks for the 3 treatment conditions (placebo, 192 mg NTX, and 384 mg NTX). Retention rates were measured twice a week. The data points labeled with the bracket indicate a clinically meaningful difference that provides justification (anchor) for the parameters chosen in the Comer et al. [10] study. Reprinted with permission from Comer et al. [11]